Los Angeles, CA -- (SBWire) -- 06/05/2019 --Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates are also used in the treatment of epilepsy, insomnia, and status epilepticus. Barbiturate drugs are available in pill form and can be taken orally and intravenously.
Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of the primary neurotransmitters in the brain known as gamma amino butyric acid (GABA). An increase in GABA has a sedative effect on the user's brain. The effect of barbiturate lasts between 4 hours and 16 hours, depending on the type and strength of the dose.
Barbiturates become dangerous when combined with other depressants such as alcohol. There is a high risk of dependency from regular use of barbiturate drugs. This can be a physical dependency, psychological dependency, or both. The amount required for overdose varies from person to person.
North America is expected to account for the largest share of the global market from 2018 to 2025, due to highest percentage of insomnia affected patients.
Get PDF of this report template: https://www.qyresearch.com/sample-form/form/984983/global-barbiturate-drugs-market
This report focuses on Barbiturate Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Barbiturate Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer
Merck
Eli Lilly
Mylan
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Valeant Pharmaceuticals
Oak Pharmaceuticals
Meda pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Segment by Type
By Drug Type
Ultra-Short Acting Barbiturate
Short-Acting Barbiturate
Long-Acting Barbiturate
Combination Drugs
By Route of Administration
Oral
Injectable
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Get Customized Report in your Inbox within 24 hours @: https://www.qyresearch.com/customize-request/form/984983/global-barbiturate-drugs-market
Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Barbiturate Drugs Market Size Analysis and Forecast (2019-2025): Merck, Eli Lilly, Mylan